Akzo Nobel India's Stock Faces Technical Shift Amid Mixed Financial Performance
Akzo Nobel India has recently experienced an evaluation adjustment reflecting shifts in its technical trends. The stock has shown mixed performance, with a notable annual return of 24.20%, while net sales growth has been modest. The company's liquidity concerns are highlighted by a low cash position despite a strong return on equity.
Akzo Nobel India, a midcap player in the paints industry, has recently undergone an evaluation adjustment that reflects changes in its underlying technical trends. The stock's technical indicators have shifted, with the overall trend moving from a sideways position to a mildly bearish stance. In terms of key metrics, the stock has shown a mixed performance across various time frames. Over the past year, Akzo Nobel India has achieved a return of 24.20%, significantly outperforming the broader market, which recorded a return of 0.37%. However, the company's net sales growth has been modest, averaging an annual rate of 8.98% over the last five years, while operating profit growth stands at 12.96%.
The stock is currently trading at a premium compared to its peers, with a Price to Book Value ratio of 12.3. Despite a high return on equity (ROE) of 25.77%, the company's cash and cash equivalents have reached a low of Rs 300.50 crore, indicating potential liquidity concerns.
Overall, the recent evaluation adjustment for Akzo Nobel India highlights the complexities of its market position and financial metrics.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
